No insider purchase over the last 90 days. The latest, by 于苏华, was filed 20 Mar 2026.
Blue Sail Medical Co.,Ltd.: what insiders have been doing
Every trade that managers of Blue Sail Medical Co.,Ltd. disclose to SSE / SZSE (CSRC) is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 4 November 2026, 2 filings were filed, from 2 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €274k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Among those who bought: 2 board members. Biggest ticket of the year: €147k, bought by 刘文静 and made public on 20 March 2026.
Compared with its exchange (521 companies, median 2 filings), a count of 2 filings is typical. Since 2021, the database holds 3 purchases and 2 sales by insiders of the company.
In the case of 2 purchases, another manager of the company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The latest purchase dates back some time: it was published 233 days ago, on 20 March 2026.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -27.3%Entry CN¥7.55 · Close 02 Nov 2026 CN¥5.49
- -27.3%Entry CN¥7.55 · Close 02 Nov 2026 CN¥5.49
- -43.5%Entry CN¥14.38 · Close at T+365 CN¥8.12
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 150,000 shares100.0% of flowA股XSHESZSE:273000000280243460Canonical exit: 18 Jun 2026 (T+90)
- 129,500 shares100.0% of flowA股XSHESZSE:273000000280243550Canonical exit: 18 Jun 2026 (T+90)
- 100 shares100.0% of flowA股XSHESZSE:173000006097461150
- 1,000 shares100.0% of flowA股XSHESZSE:173000005436862000
- 208,000 shares100.0% of flowA股XSHESZSE:173000005011564030Canonical exit: 25 Jan 2022 (T+90)
5 of 5 declarations
About Blue Sail Medical Co.,Ltd.
蓝帆医疗 is a company focused on the healthcare and pharmaceutical sector, providing medical products and healthcare solutions. It is listed on the XSHE market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
